对抗高血压药物的周术管理
Jason F Shiffermiller1, Zahid Iqbal2, Michael P Smith3
1Division of Hospital Medicine, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA - jshiffermiller@unmc.edu.
Minerva medica
|March 7, 2025
概括
在手术前对服用抗高血压药物的患者进行管理是复杂的. 本综述指导了外科手术期间高血压的管理,重点关注常见的药物类别和基于证据的建议,以获得最佳的患者结果.
科学领域:
- 心脏病学 心脏病学
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
背景情况:
- 超过一半的接受手术前评估的患者正在服用抗高血压药物.
- 管理各种抗高血压药物类别和组合存在重大临床挑战.
- 低于最佳的血压控制和相互矛盾的证据使术后管理复杂化.
研究的目的:
- 审查影响术前高血压管理决策的因素.
- 总结关于常见抗高血压药物的证据 (ACE抑制剂,ARB,β-阻断剂,利尿剂).
- 提供有关术前和术后血压管理的指导.
主要方法:
- 在外科手术期间对抗高血压药物管理的文献综述.
- 对常见抗高血压药物类别的证据分析.
- 专家指导和临床建议的综合.
主要成果:
- 讨论手术前高血压管理的关键因素.
- 关于血管激素转化酶抑制剂,血管激素受体阻断剂,β-阻断剂和利尿剂的证据总结.
- 术前和术后血压控制的考虑因素.
结论:
- 适当的抗高血压药物管理对于术后结果至关重要,包括死亡率.
- 根据现有证据和专家指导方针提供建议.
- 由于患者的变异性,个性化,逐个案例的临床决定是必不可少的.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
404
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404
General Anesthesia: Overview
198
Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
198
Parenteral Anesthetics: Overview
111
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
111
Antihypertensive Drugs: Direct Renin Inhibitors
511
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
511
Antianginal Drugs: Nitrates and β-Blockers
547
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
547
Local Anesthetics: Pharmacokinetics
747
The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
747


